These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331 [TBL] [Abstract][Full Text] [Related]
12. Low-Grade Albuminuria Is Associated with Left Ventricular Hypertrophy and Diastolic Dysfunction in Patients with Hypertension. Wang T; Zhong H; Lian G; Cai X; Gong J; Ye C; Xie L Kidney Blood Press Res; 2019; 44(4):590-603. PubMed ID: 31387099 [TBL] [Abstract][Full Text] [Related]
13. Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension. Cuspidi C; Michev I; Meani S; Severgnini B; Fusi V; Corti C; Salerno M; Valerio C; Magrini F; Zanchetti A J Hum Hypertens; 2003 Apr; 17(4):245-51. PubMed ID: 12692569 [TBL] [Abstract][Full Text] [Related]
14. Relationship between microalbuminuria and cardiac structural changes in mild hypertensive patients. Plavnik FL; Silva MA; Kohlmann NE; Kohlmann O; Ribeiro AB; Zanella MT Braz J Med Biol Res; 2002 Jul; 35(7):799-804. PubMed ID: 12131919 [TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension. Redon J; Baldo E; Lurbe E; Bertolin V; Lozano JV; Miralles A; Pascual JM Kidney Int Suppl; 1996 Jun; 55():S81-4. PubMed ID: 8743518 [TBL] [Abstract][Full Text] [Related]
16. Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus. Picca M; Agozzino F; Pelosi G Ital Heart J; 2003 Jan; 4(1):48-52. PubMed ID: 12690921 [TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria as a marker of cardiac damage in essential hypertension. Mettimano M; Specchia ML; Migneco A; Savi L Eur Rev Med Pharmacol Sci; 2001; 5(1):31-6. PubMed ID: 11860221 [TBL] [Abstract][Full Text] [Related]
18. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. Ravera M; Ratto E; Vettoretti S; Viazzi F; Leoncini G; Parodi D; Tomolillo C; Del Sette M; Maviglio N; Deferrari G; Pontremoli R J Nephrol; 2002; 15(5):519-24. PubMed ID: 12455718 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Palatini P; Graniero GR; Mormino P; Mattarei M; Sanzuol F; Cignacco GB; Gregori S; Garavelli G; Pegoraro F; Maraglino G; Bortolazzi A; Accurso V; Dorigatti F; Graniero F; Gelisio R; Businaro R; Vriz O; Dal Follo M; Camarotto A; Pessina AC Am J Hypertens; 1996 Apr; 9(4 Pt 1):334-41. PubMed ID: 8722436 [TBL] [Abstract][Full Text] [Related]
20. Determinants of left ventricular function before and after regression of myocardial hypertrophy in hypertension. Grandi AM; Venco A; Sessa F; Gola A; Pantaleo P; Gobbi G; Baiardini R; Finardi G Am J Hypertens; 1993 Aug; 6(8):708-12. PubMed ID: 8217034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]